Tra2β exerts tumor‐promoting effects via GSK3 /β‐catenin signaling in oral squamous cell carcinoma
Oral Diseases · 2024
DOI: 10.1111/odi.14949 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2024. Verfasst von Xiaofen Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, Wenshui County People's Hospital of Shanxi Province, Wenshui, China. Hauptthemen laut MEDLINE: Mouth Neoplasms, Carcinoma, Squamous Cell, beta Catenin, Serine-Arginine Splicing Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Shanxi Natural Science Foundation of China, Shanxi Basic Research Program of China, Shanxi Bethune Hospital Talent Introduction Research Start-up Fund of China.
Abstract (Originalsprache)
Objectives
The splicing factor transformer‐2 homolog beta (Tra2β) plays a pivotal role in various cancers. Nonetheless, its role in oral squamous cell carcinoma (OSCC) has not been comprehensively explored. This study sought to discern the influence of Tra2β on OSCC and its underlying mechanisms. Materials and Methods We assessed Tra2β expression in OSCC utilizing immunohistochemistry, qRT‐PCR, and western blotting techniques. siRNA transfection was used to silence Tra2β. Whole transcriptome RNA sequencing (RNA‐seq) analysis was carried out to reveal the alternative splicing (AS) events. KEGG pathway analysis enriched the related pathways. Colony formation, transwell, wound healing, and Annexin V‐FITC/PI were employed to appraise the consequences of Tra2β silencing on OSCC.
Results
Tra2β was highly expressed in both OSCC tissues and cell lines. Knockdown of Tra2β‐regulated AS events with skipped exon (SE) accounts for the highest proportion. Meanwhile, downregulation of Tra2β reduced cell proliferation, migration, and invasion, however increasing cell apoptosis. Moreover, Wnt signaling pathway involved in the function of Tra2β knockdown which was demonstrated directly by a discernible reduction in the expression of GSK3/β‐catenin signaling axis.
Conclusions
These findings suggest that knockdown of Tra2β may exert anti‐tumor effects through the GSK3/β‐catenin signaling pathway in OSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, Wenshui County People's Hospital of Shanxi Province, Wenshui, China.
- Shanxi Medical University School and Hospital of Stomatology, Taiyuan, China.
- Department of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, China.
- Shanxi Traditional Chinese Medical Hospital, Taiyuan, China.
- Department of Basic Medical Sciences, Shanxi Medical University, Taiyuan, China.
- Laboratory Animal Center, Shanxi Key Laboratory of Experimental Animal Science and Human Disease Animal Model, Shanxi Medical University, Taiyuan, China.
ORCID-Profile: Xiaofen Wu, Xinyue Zhou, Guohua Song, Xiaohong Guo, Rui Sun
Förderung
- Shanxi Natural Science Foundation of China
- Shanxi Basic Research Program of China
- Shanxi Bethune Hospital Talent Introduction Research Start-up Fund of China
- Science and Technology Innovation Teams of Shanxi Province
- National Natural Science Foundation of China
Zitieren
APA
Wu, X., Zhou, X., Sun, X., Ning, Y., Song, X., Song, G., Guo, X., & Sun, R. (2024). Tra2β exerts tumor‐promoting effects via GSK3 /β‐catenin signaling in oral squamous cell carcinoma. Oral Diseases. https://doi.org/10.1111/odi.14949
Vancouver
Wu X, Zhou X, Sun X, Ning Y, Song X, Song G, et al. Tra2β exerts tumor‐promoting effects via GSK3 /β‐catenin signaling in oral squamous cell carcinoma. Oral Diseases. 2024. doi:10.1111/odi.14949
BibTeX
@article{Wu2024,
author = {Wu, Xiaofen and Zhou, Xinyue and Sun, Xiaozhen and Ning, Yi and Song, Xiaona and Song, Guohua and Guo, Xiaohong and Sun, Rui},
title = {Tra2β exerts tumor‐promoting effects via GSK3 /β‐catenin signaling in oral squamous cell carcinoma},
journal = {Oral Diseases},
year = {2024},
doi = {10.1111/odi.14949}
}
EUVIMED